Biopathology Lab Accreditation for Molecular Diagnosis Confirms Once More the Top Level of Services

The Molecular Diagnosis Lab within the IASO Central Laboratories has been accredited by the National Accreditation System (ESYD) to ISO 15189:2012, for the following real-time PCR tests:

  • Detection of SARS-CoV-2
  • Detection of human papillomavirus (HPV)
  • Detection and quantitative DNA determination of human cytomegalovirus (HCMV)
  • Detection of influenza types A and B, and subtype A (Η1Ν1)

The exact scope of Accreditation Certificate no. 1245 is explained in detail in the relevant Official Accreditation Scope dated 08/04/2021 (http://bit.ly/IASO_Certifications-Accreditations).

ISO 15189:2012 is an international standard that sets out the requirements laboratories must meet to maintain a quality management system, and ensure their technical adequacy and the credibility of the results they issue through validated methods of analysis.

This accreditation confirms once more the top level of services offered. By applying international standards, IASO validates its superiority, becoming a leading healthcare services provider throughout Greece.

 

For more news-related information: Nancy Christopoulou, Commercial Division, IASO Group, Tel.: (+30) 210 6383917, Email: [email protected]

    View also:

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”
    GENERAL

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”

    IASO General Clinic in collaboration with the Internal Medicine - Infectious Diseases Clinic is organizing a One-Day Conference on the topic: “Infections in Obstetrics and Gynecology”, which will be held on Saturday, October 11th, 2025, at 09:00, at IASO Hospital’s Event Hall (37-39 Kifissias Ave, Maroussi). The aim of the Conference is to highlight the importance of early diagnosis and p...

    IASO General Clinic: Robotic mastectomy and reconstruction
    GENERAL

    IASO General Clinic: Robotic mastectomy and reconstruction

    A pioneering Robotic double Mastectomy and Reconstruction was successfully performed at IASO General Clinic on a 42-year-old woman who is a carrier of the BRCA1 gene, which is responsible for hereditary breast cancer, with the use of...

    IASO General Clinic: Advanced Medical Imaging with the New Discovery MI Gen2 PET/CT System
    GENERAL

    IASO General Clinic: Advanced Medical Imaging with the New Discovery MI Gen2 PET/CT System

    Cutting-edge technology in the service of personalized care IASO Group is ushering in a new era in diagnostic imaging through the installation...